Literature DB >> 3161682

Photodynamic therapy.

T J Dougherty.   

Abstract

Photodynamic therapy for treatment of malignant tumors uses certain porphyrins as relatively tumor-selective photosensitizers. A wide variety of tumors take up and retain these materials, which can result in complete eradication of the local tumor provided that light of the proper wavelength and sufficient dose is used. This therapy appears to be particularly applicable to treatment of early-stage lung and bladder cancer and can be palliative for several other more advanced cancers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161682

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  4 in total

1.  Photodynamic sensitizers assay: rapid and sensitive iodometric measurement.

Authors:  J Mosinger; B Mosinger
Journal:  Experientia       Date:  1995-02-15

2.  Ir(III) Complex Dimer Nanoparticles for Photodynamic Therapy.

Authors:  Yingjie Liu; Dongxia Zhu; Zhigang Xie
Journal:  ACS Med Chem Lett       Date:  2021-08-06       Impact factor: 4.632

3.  In vivo photobleaching kinetics and epithelial biodistribution of hexylaminolevulinate-induced protoporphyrin IX in rat bladder cancer.

Authors:  Sami El Khatib
Journal:  Curr Urol       Date:  2021-03-29

4.  Photodynamic therapy for middle-advanced stage upper gastrointestinal carcinomas: A systematic review and meta-analysis.

Authors:  Bo Chen; Li Xiong; Wei-Dong Chen; Xiao-Hua Zhao; Jun He; Yan-Wen Zheng; Fan-Hua Kong; Xi Liu; Zi-Jian Zhang; Xiong-Ying Miao
Journal:  World J Clin Cases       Date:  2018-11-06       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.